CDCP1 and invasive breast carcinoma: Overall, the immunohistochemical data indicate that a significant proportion of bladder carcinomas, invasive breast carcinomas, colon adenocarcinomas, lung squamous cell carcinomas, PDACs and prostate adenocarcinomas display expression of CDCP1 protein that is markedly elevated above levels seen in normal tissues.